Invesco Ltd. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$35,000
-50.0%
31,078
-0.2%
0.00%
Q4 2021$70,000
-33.3%
31,136
+1.0%
0.00%
Q3 2021$105,000
+50.0%
30,832
+31.9%
0.00%
Q2 2021$70,000
+366.7%
23,384
+80.5%
0.00%
Q4 2018$15,000
-59.5%
12,955
-4.0%
0.00%
Q3 2018$37,000
+23.3%
13,501
-13.1%
0.00%
Q2 2018$30,000
-31.8%
15,544
-52.2%
0.00%
Q4 2016$44,000
-12.0%
32,543
+1.6%
0.00%
Q3 2016$50,000
+38.9%
32,025
+19.7%
0.00%
Q2 2016$36,000
-72.1%
26,758
+9.0%
0.00%
Q1 2016$129,000
-96.8%
24,539
-93.3%
0.00%
-100.0%
Q2 2015$4,039,000
-80.5%
368,812
-75.2%
0.00%
-75.0%
Q1 2015$20,751,000
+195.1%
1,484,322
+256.6%
0.01%
+166.7%
Q4 2014$7,031,000
+485.9%
416,268
+365.5%
0.00%
Q3 2014$1,200,000
-20.5%
89,422
-24.6%
0.00%
-100.0%
Q2 2014$1,510,000
+4.9%
118,539
-2.1%
0.00%0.0%
Q1 2014$1,440,000
-0.6%
121,065
+15.5%
0.00%0.0%
Q4 2013$1,448,000
-74.3%
104,851
-67.5%
0.00%
-50.0%
Q3 2013$5,624,000
+39.8%
322,657
+29.9%
0.00%0.0%
Q2 2013$4,022,000248,4020.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,354,963$38,132,0001.80%
Orbimed Advisors 4,520,800$73,201,0001.55%
QVT Financial LP 1,326,610$21,480,0001.44%
BB BIOTECH AG 1,089,828$17,646,0001.27%
Meditor Group Ltd 250,000$4,048,0000.55%
Perimeter Capital Partners, LLC 159,915$2,589,0000.50%
EMERALD MUTUAL FUND ADVISERS TRUST 156,808$2,539,0000.43%
Broadfin Capital, LLC 117,172$1,897,0000.37%
OXFORD ASSET MANAGEMENT LLP 811,331$13,184,0000.36%
Baker Brothers Advisors 1,016,433$16,458,0000.33%
View complete list of INFINITY PHARMACEUTICALS INC shareholders